Probucol and multivitamins in the prevention of restenosis after coronary angioplasty

New England Journal of Medicine

Volumn 337, Issue 6, 1997, Pages 365-372

  Tardif, Jean Claude ^a   Côté, Gilles ^a   Lespérance, Jacques ^a   Bourassa, Martial ^a   Lambert, Jean ^b   Doucet, Serge ^a   Bilodeau, Luc ^a   Nattel, Stanley ^a   De Guise, Pierre ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; MULTIVITAMIN; PROBUCOL;

ADULT; ANGIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; DATA ANALYSIS; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; OXIDATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIOXIDANTS; ASCORBIC ACID; BETA CAROTENE; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROBUCOL; RECURRENCE; TREATMENT OUTCOME; VITAMIN E;

EID: 1842338658     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199708073370601     Document Type: Article

References (42)

1. Landau C, Lange RA, Hillis LD. Percutaneous transluminal coronary angioplasty. N Engl J Med 1994;330:981-93.
2. Ferns GAA, Forster L, Stewart-Lee A, Konneh M, Nourooz-Zadeh J, Anggard EE. Probucol inhibits neointimal thickening and macrophage accumulation after balloon injury in the cholesterol-red rabbit. Proc Natl Acad Sci USA 1992;89:11312-6.
3. Schneider JE, Berk BC, Gravanis MB, et al. Probucol decreases neointimal formation in a swine model of coronary artery balloon injury: a possible role for antioxidants in restenosis. Circulation 1993;88:628-37
4. Freyschuss A, Stiko-Rahm A, Swedenborg J, et al. Antioxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta in hypercholesterolemic rabbits. J Clin Invest 1993;91:1282-8.
5. Nunes GL, Sgoutas DS, Redden RA, et al. Combination of vitamins C and E alters the response to coronary balloon injury in the pig. Arterioscler Thromb Vasc Biol 1995;15:156-65.
6. Lee YJ, Yamaguchi H, Daida H, et al. Pharmacological interventions to modify restenosis. Circulation 1991;84:Suppl II:II-299. abstract.
7. Setsuda M, Inden M, Hiraoka N, et al. Probucol therapy in the prevention of restenosis after successful percutaneous transluminal coronary angioplasty. Clin Ther 1993;15:374-82.
8. Watanabe K, Sekiya M, Ikeda S, Miyagawa M, Hashida K. Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 1996;132:23-9.
9. Yokoi H, Yamaguchi H, Kuwabara Y. Effectiveness of probucol in preventing restenosis after percutaneous transluminal coronary angioplasty: Probucol Angioplasty Restenosis Trial (PART). J Am Coll Cardiol 1996; 27:Suppl A:391A. abstract.
10. DeMaio SJ, King SB III, Lembo NJ, et al. Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA). J Am Coll Nutr 1992;11:68-73.
11. Burke BS. The dietary history as a tool in research. J Am Diet Assoc 1947;23:1041-6.
12. Health and Welfare Canada. Canadian nutrient file. Ottawa, Ont.: Supply and Services Canada, 1991.
13. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Arch Intern Med 1988;148:36-69.
14. Beaudry M, Galibois I, Chaumette P. Assessing the quality of food intake with the 1990 nutrition recommendations: four indicators proposed. J Can Diet Assoc 1996;57:7-11.
15. Schäfer-Elinder L, Walldius G. Simultaneous measurement of serum probucol and lipid-soluble antioxidants. J Lipid Res 1992;33:131-7.
16. Reiber JHC, van der Zwet PMJ, von Land CD, et al. Quantitative coronary arteriography: equipment and technical requirements. In: Reiber JHC, Serruys PW, eds. Advances in quantitative coronary arteriography. Vol. 137 of Developments in cardiovascular medicine. Dordrecht, the Netherlands: Kluwer Academic, 1993:75-111.
17. Lespérance J, Waters D. Measuring progression and regression of coronary atherosclerosis in clinical trials: problems and progress. Int J Card Imaging 1992;8:165-73.
18. Schwartz L, Bourassa MG, Lespérance J, et al. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 1988;318:1714-9.
19. Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
20. Pocock SJ. Group sequential methods in the design and analysis of clinical trials. Biometrika 1977;64:191-9.
21. O'Keefe JH Jr, Stone GW. McCallister BD Jr, et al. Lovastatin plus probucol for prevention of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1996;77:649-52.
22. Reaven PD, Parthasarathy S, Beltz WH, Witztum JL. Effect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotein against in vitro oxidation in humans. Arterioscler Thromb 1992;12:318-24.
23. Southorn PA, Powis G. Free radicals in medicine. I. Chemical nature and biologic reactions. Mayo Clin Proc 1988;63:381-9.
24. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 1990;344:160-2.
25. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotcin that increase its atherogenicity. N Engl J Med 1989;320:915-24.
26. Strauss BH, Chisholm RJ, Keeley FW, Gotlieb AI, Logan RA, Armstrong PW. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res 1994;75:650-8.
27. Currier JW, Faxon DP. Restenosis after percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target? J Am Coll Cardiol 1995;25:516-20.
28. Langille BL, O'Donnell F. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science 1986;231:405-7.
29. Steinberg D. Studies on the mechanism of action of probucol. Am J Cardiol 1986;57:16H-21H.
30. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995;332:488-93.
31. Parthasarathy S, Young SG, Witztum JL, Pittman RC, Steinberg D. Probucol inhibits oxidative modification of low density lipoprotein. J Clin Invest 1986;77:641-4.
32. Weintraub WS, Boccuzzi SJ, Klein JL, et al. Lack of effect of lovastatin on restenosis after coronary angioplasty. N Engl J Med 1994;331:1331-7.
33. Ku G, Doherty NS, Wolos JA, Jackson RL. Inhibition by probucol of interleukin 1 secretion and its implication in atherosclerosis. Am J Cardiol 1988;62:77B-81B.
34. Galis ZS, Muszynski M, Sukhova GK, et al. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 1994;75:181-9.
35. Jialal I, Grundy SM. Effect of dietary supplementation with alphatocopherol on the oxidative modification of low density lipoprotein. J Lipid Res 1992;33:899-906.
36. Burton GW, Ingold KU. Vitamin E as an in vitro and in vivo antioxidant. Ann N Y Acad Sci 1989;570:7-22.
37. Brin MF, Fahn S, Loftus S, McMahon D, Flaster E. Relationship between dose of vitamin E administered and blood level. Ann N Y Acad Sci 1989;570:421-4.
38. Cavarocchi NC, England MD, O'Brien JF, et al. Superoxide generation during cardiopulmonary bypass: is there a role for vitamin E? J Surg Res 1986;40:519-27.
39. Kagan VE, Serbinova EA, Forte T, Scita G, Packer L. Recycling of vitamin E in human low density lipoproteins. J Lipid Res 1992;33:385-97.
40. Shaish A, Daughterty A, O'Sullivan F, Schonfeld G, Heinecke JW. Betacarotene inhibits atherosclerosis in hypercholesterolemic rabbits. J Clin Invest 1995;96:2075-82.
41. Keaney JF Jr, Gaziano JM, Xu A, et al. Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol fed rabbits. Proc Natl Acad Sci U S A 1993;90:11880-4.
42. Burton GW, Ingold KU. β-Carotene: an unusual type of lipid antioxidant. Science 1984;224:569-73.